Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-11 Sale | 2024-03-11 5:19 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 15,409 | $0.882 | $13,591 | 291,752 (Direct) | View |
| 2024-02-12 Sale | 2024-02-12 5:23 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 3,683 | $1.007 | $3,709 | 307,161 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 4:40 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 67,695 | $0.73 | $49,417 | 310,844 (Direct) | View |
| 2023-09-08 Sale | 2023-09-12 4:04 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 2,642 | $1.249 | $3,300 | 147,894 (Direct) | View |
| 2023-06-30 Sale | 2023-07-05 4:05 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 464 | $1.89 | $877 | 150,536 (Direct) | View |
| 2023-06-23 Sale | 2023-06-26 4:15 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 857 | $1.93 | $1,654 | 151,000 (Direct) | View |
| 2023-06-15 Sale | 2023-06-16 4:24 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 857 | $2.23 | $1,911 | 151,857 (Direct) | View |
| 2023-03-10 Sale | 2023-03-13 4:52 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 18,192 | $0.84 | $15,281 | 152,714 (Direct) | View |
| 2023-02-13 Sale | 2023-02-15 5:13 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 4,348 | $0.93 | $4,044 | 170,906 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 1:07 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 1,713 | $0 | $0 | 177,896 (Direct) | View |
| 2022-06-30 Sale | 2022-07-01 4:56 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 1,578 | $0 | $0 | 179,609 (Direct) | View |
| 2022-06-24 Sale | 2022-06-27 4:09 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 856 | $0 | $0 | 181,187 (Direct) | View |
| 2022-06-16 Sale | 2022-06-17 4:21 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 856 | $0 | $0 | 182,043 (Direct) | View |
| 2022-02-11 Sale | 2022-02-14 4:22 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 12,545 | $0 | $0 | 77,899 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award | 2024-02-16 5:09 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 428,248 | $0 | 428,248 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-02 4:55 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 230,645 | $0 | 378,539 (Direct) | View |
| 2022-11-07 Option Award | 2022-11-09 4:23 pm | N/A 2032-11-07 | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 1,350,000 | $0 | 1,350,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-01 4:16 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 105,000 | $0 | 182,899 (Direct) | View |
| 2021-09-08 Option Award | 2021-09-10 4:10 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 27,000 | $0 | 90,444 (Direct) | View |
Ownership | 2021-09-10 4:08 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 0 | $0 | 131,161 (Direct) | View |